Clinical Trial Update: Effects of Denosumab on the Pharmacokinetics of Etanercept [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating whether denosumab affects the pharmacokinetics of etanercept; the study was terminated with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteopenia
• Osteoporosis
• Rheumatoid Arthritis

Drugs mentioned

• Denosumab (denosumab)
• Etanercept (etanercept)

Snippet

Sponsor: Amgen | Conditions: Postmenopausal, Osteopenia | Phase 1 | Status: TERMINATED | Results posted: 2017-06-20